Rishi R. Paudel

Statistics

Publications

Citations

155

H-Index

Active since

2017

Affiliations

University of Missouri–St. Louis(Current)

Centre National de la Recherche Scientifique

Aix-Marseille Université

Université de Montpellier

Inserm

Rishi R. Paudel is an author at University of Missouri–St. Louis specializing in antibacterial pharmacology, tuberculosis drug development, and pharmacology.

ORCID

Publications per year

2017–2024

Publications

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis

Phuong Chi Nguyen, Vincent Delorme, Anaïs Bénarouche et al. · Scientific Reports · 2017 · 53 citations · Full text

Medicine, Microbiology, Pharmacology +14

Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of <i>Mycobacterium abscessus</i>

Abdeldjalil Madani, Jeremy N. Ridenour, Benjamin Martin et al. · ACS Infectious Diseases · 2019 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases

Phuong Chi Nguyen, Abdeldjalil Madani, Pierre Santucci et al. · International Journal of Antimicrobial Agents · 2017 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Development of a RIPK1 degrader to enhance antitumor immunity

Xin Yu, Dong Lu, Xiaoli Qi et al. · Nature Communications · 2024 · 25 citations · Full text

Life Sciences, Immunology, Oncology +17

1–4 of 4